Newsfeeds - Spark Newswire

3 minute read

US Stock Futures Edge Higher; All Eyes On Fed Decision

Today, 3:56 PM

Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade on Wednesday after recording losses on Tuesday. The Dow Jones closed lower by more than 300 points, while the Nasdaq Composite fell over 100 points in the previous session.

ALPN

1 minute read

Alpine Immune Sciences Priced ~13.6M Share Public Offering of Common Stock @$7.35/Share

By Charles Gross

Today, 3:56 PM

Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the pricing of its underwritten public offering of 13,606,000 shares of its common stock pursuant to its existing shelf registration statement. The shares of common stock are being offered at a public offering price of $7.35 per share.

ALPN

1 minute read

General Mills, Lennar And 3 Stocks To Watch Heading Into Wednesday

By Lisa Levin

Today, 3:56 PM

With US stock futures trading slightly lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

ALPN

1 minute read

At R&D Day, Alpine Immune Highlights Updates On Autoimmune, Immuno-Oncology Programs

By Vandana Singh

Today, 3:56 PM

Alpine Immune Sciences Inc (NASDAQ:ALPN) announced clinical updates from ALPN-303 and davoceticept programs. Key highlights from the announcement include: ALPN-303 Well…

ALPN

1 minute read

Earnings

Alpine Immune Sciences: Q2 Earnings Insights

By Benzinga Insights

Today, 3:56 PM

Alpine Immune Sciences (NASDAQ:ALPN) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

ALPN

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

Today, 3:56 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP

3 minute read

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton’s Partnered Epilepsy Drug, ASCO Conference Gets Underway And More

By Shanthi Rexaline

Today, 3:56 PM

Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for the year-to-date period.

ABBV

1 minute read

FDA Lifts Partial Hold On Alpine Immune’s Davoceticept Combo Trial In Advanced Cancer

By Vandana Singh

Today, 3:56 PM

The FDA has removed the partial clinical hold placed on Alpine Immune Sciences Inc’s (NASDAQ:ALPN) NEON-2 trial of davoceticept (ALPN-202) in advanced…

ALPN

1 minute read

Alpine Immune’s Davoceticept Monotherapy Reduces Tumors In Early Stage Study

By Vandana Singh

Today, 3:56 PM

Alpine Immune Sciences Inc (NASDAQ: ALPN)

ALPN

2 minute read

Alpine Immune Sciences Highlights Oral Presentation Of Results From Dose-Escalation Of NEON-1 Study Of Its DavoceticeptMonotherapy At American Association For Cancer Research

By Benzinga Newsdesk

Today, 3:56 PM

- In dose escalation across a range of dose regimens, tumor volume reduction was observed in 23% of evaluable participants despite heavily pretreated, advanced solid malignancies - - Monotherapy expansion cohorts with

ALPN